ARTICLE | Clinical News
Lurbinectedin: Phase III started
August 8, 2016 7:00 AM UTC
PharmaMar began the open-label, international Phase III ATLANTIS trial to compare PM1183 plus doxorubicin vs. topotecan or cyclophosphamide plus doxorubicin and vincristine in 600 patients with SCLC w...